Truvada
Gilead loses appeal to prevent generic HIV drug entering Irish market
The Court of Appeal has dismissed an appeal by Gilead Sciences aiming to halt two companies who produce and supply generic HIV drugs from putting any product containing a combination of two particular anti-retroviral agents on the Irish market. On Tuesday, February 2, the Court of Appeal upheld a High Court decision revoking Gilead’s supplemental […]